Current pharmacotherapy for the treatment of crescentic glomerulonephritis

被引:10
|
作者
Tam, Frederick W. K. [1 ]
机构
[1] Hammersmith Hosp, Imperial Coll London, Renal Sect, Div Med,W London Renal & Transplant Ctr, London W12 0NN, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
autoimmunity; cytokine; glomerulonephritis; immunosuppressive therapy; inflammation; p38; MAPK; plasma exchange; renal failure; TNF;
D O I
10.1517/13543784.15.11.1353
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glomerulonephritis is an important cause of end-stage renal disease. Crescentic glomerulonephritis is the most severe form of glomerulonephritis and, if untreated, patients will develop renal failure within days or weeks of diagnosis. Current immunotherapy consists of corticosteroids, cytotoxic drugs and plasma exchange. Challenges include minimising toxicity of therapy, preventing relapse in antineutrophil cytoplasmic antibodies-associated vasculitis and finding an effective treatment for crescentic IgA nephropathy. There are opportunities for more specific therapies using monoclonal antibodies to T cells (and their co-stimulatory receptors), B cells and cytokines, or pharmacological inhibitors of signal transduction. Their efficacy and safety remain to be established with controlled clinical trials. Recent development of urinary cytokine measurement provides a noninvasive biomarker of renal disease activity, which is useful in monitoring response to therapy and assessing prognosis.
引用
收藏
页码:1353 / 1369
页数:17
相关论文
共 50 条
  • [1] TREATMENT AND OUTCOME IN CRESCENTIC GLOMERULONEPHRITIS
    AHMAD, S
    YOUNG, J
    QUADRACCI, L
    STRIKER, G
    SCRIBNER, BH
    KIDNEY INTERNATIONAL, 1979, 16 (06) : 924 - 924
  • [2] CRESCENTIC GLOMERULONEPHRITIS
    DUMAS, R
    ANNALES DE PEDIATRIE, 1994, 41 (01): : 52 - 59
  • [3] Crescentic glomerulonephritis
    Jennette, JC
    Thomas, DB
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 : 80 - 82
  • [4] Plasmapheresis in treatment of acute oligoanuria in crescentic glomerulonephritis
    Department of Nephrology, University Clinical Center, Skopje, Macedonia
    不详
    Artif. Organs, 10 (827-830):
  • [5] Plasmapheresis in treatment of acute oligoanuria in crescentic glomerulonephritis
    Grcevska, L
    Polenakovic, M
    Stojkovski, L
    Polenakovic, H
    ARTIFICIAL ORGANS, 1998, 22 (10) : 827 - 830
  • [6] CRESCENTIC GLOMERULONEPHRITIS ASSOCIATED WITH ANTITHYROID DRUG TREATMENT
    Khedhiri, Azza
    Chaabouni, Yosr
    Agrebi, Ikram
    Talmoudi, Aicha
    Feriani, Houda
    Dammak, Najla
    Kharrat, Mahmoud
    Jarraya, Fayal
    Ben Hmida, Mohamed
    Kammoun, Khawla
    Boudawara, Tahya
    Hachicha, Jamil
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 411 - 412
  • [7] Monthly cyclophosphamide pulses in the treatment of crescentic glomerulonephritis
    De La Torre, M
    Alcázar, R
    Urra, JM
    Caparrós, G
    Alegre, R
    Blanco, J
    Nieto, J
    Ferreras, I
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (08) : 3952 - 3954
  • [8] PULSE METHYLPREDNISOLONE THERAPY IN THE TREATMENT OF ACUTE CRESCENTIC GLOMERULONEPHRITIS
    FERRARIS, JR
    GALLO, GE
    RAMIREZ, J
    IOTTI, R
    GIANANTONIO, C
    NEPHRON, 1983, 34 (03): : 207 - 208
  • [9] Plasmapheresis for the Treatment of Crescentic Postinfectious Glomerulonephritis: A Case Report
    Gokalp, Cenk
    Turkoglu, Rabia Gizem
    Yildiz, Faruk
    Usta, Ufuk
    Kurultak, Ilhan
    Ustundag, Sedat
    BLOOD PURIFICATION, 2020, 49 (1-2) : 125 - 128
  • [10] Rapidly progressive crescentic glomerulonephritis: Early treatment is a must
    Moroni, Gabriella
    Ponticelli, Claudio
    AUTOIMMUNITY REVIEWS, 2014, 13 (07) : 723 - 729